long COVID symptoms

Paxlovid Fails to Reduce Long COVID Symptoms in NIH Clinical Trial

September 1, 2026

Extended courses of the antiviral drug Paxlovid do not reduce long COVID symptoms compared to placebo, according to clinical trial results published in the journal Lancet…

Severe COVID-19 can reactivate dormant viruses, new study reveals

August 11, 2026

Severe COVID-19 can reactivate dormant viruses hidden in the human body, such as the Epstein-Barr virus and Anelloviridae, according to a large observational study published in … Read more

Sections

Editorial

Legal